HPV阴性头颈部鳞癌长链非编码RNA差异表达及预后价值
该研究通过qRT-PCR阵列检测19对HPV阴性头颈部鳞癌肿瘤与正常组织的lncRNA表达,并用TCGA数据验证。验证了5个lncRNA的差异表达,发现MEG3表达与3年无复发生存率呈负相关,低MEG3表达与良好3年RFS相关。
要点
- 在HPV阴性HNSCC中验证了SPRY4-IT1、HEIH、LUCAT1、LINC00152和HAND2-AS1的差异表达。
- MEG3表达与3年RFS呈负相关,低表达与有利生存相关但意义不明。
- TCGA验证了5个lncRNA的差异表达,但MEG3在TCGA肿瘤中差异不显著。
核心结论
- 在HPV阴性HNSCC中识别并验证了5个lncRNA的差异表达。
- 低MEG3表达与有利的3年RFS相关,但该发现的意义尚不明确。
研究设计与样本
- 通过qRT-PCR阵列检测19对HPV阴性HNSCC肿瘤与正常组织的lncRNA表达。
- 使用TCGA数据验证差异表达结果,并分析差异表达lncRNA与生存结局的关联。
主要发现
- 验证了5个lncRNA(SPRY4-IT1、HEIH、LUCAT1、LINC00152和HAND2-AS1)的差异表达。
- MEG3表达与3年RFS呈负相关,MEG3在TCGA肿瘤中差异不显著但表达高度可变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Long non-coding RNA (lncRNA) has emerged as a new avenue of interest due to its various biological functions in cancer. Abnormal expression of lncRNA has been reported in other malignancies but has been understudied in head and neck squamous cell carcinoma (HNSCC). METHODS: The lncRNA expression was interrogated via quantitative real-time polymerase chain reaction (qRT-PCR) array for 19 human papillomavirus (HPV)-negative HNSCC tumor-normal pairs. The Cancer Genome Atlas (TCGA) was used to validate these results. The association between differentially expressed lncRNA and survival outcomes was analyzed. RESULTS: Differential expression was validated for 5 lncRNA (SPRY4-IT1, HEIH, LUCAT1, LINC00152, and HAND2-AS1). There was also an inverse association between MEG3 expression (not significantly differentially expressed in TCGA tumors but highly variable expression) and 3-year recurrence-free survival (RFS). CONCLUSION: We identified and validated differential expression of 5 lncRNA in HPV-negative HNSCC. Low MEG3 expression was associated with favorable 3-year RFS, although the significance of this finding remains unclear.
引用
- Haque SU, Niu L, Kuhnell D, et al. Differential expression and prognostic value of long non-coding RNA in HPV-negative head and neck squamous cell carcinoma. Head Neck. 2018. PMID: 29575229. doi:10.1002/hed.25136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。